Half Year 2024 Circio Holding ASA Earnings Call TranscriptAug 29, 2024kr1.35 (+3.86%)Earnings- Q4 2022 Targovax ASA Earnings Call TranscriptFeb 16, 2023kr31.09 (+3.35%)Earnings
- Q3 2022 Targovax ASA Earnings Call TranscriptNov 03, 2022kr34.41 (-2.35%)Earnings
- Q2 2022 Targovax ASA Earnings Call TranscriptAug 18, 2022kr42.58 (-8.06%)Earnings
- Q1 2022 Targovax ASA Earnings Call TranscriptMay 12, 2022kr44.12 (-4.97%)Earnings
- Q4 2021 Targovax ASA Earnings Presentation TranscriptFeb 17, 2022
- Q3 2021 Targovax ASA Earnings Call TranscriptNov 04, 2021kr125.93 (-6.31%)Earnings
- Q2 2021 Targovax ASA Earnings Call TranscriptAug 18, 2021kr167.1 (-5.48%)Earnings
- Q1 2021 Targovax ASA Earnings Call TranscriptMay 06, 2021kr179.21 (-4.39%)Earnings
- Targovax ASA Corporate Analyst Meeting TranscriptFeb 18, 2021
- Targovax ASA - Special Call TranscriptDec 02, 2020
- Q3 2020 Targovax ASA Earnings Call TranscriptNov 05, 2020kr166.13 (+9.94%)Earnings
- Q2 2020 Targovax ASA Earnings Call TranscriptAug 20, 2020kr159.35 (-2.52%)Earnings
- Targovax ASA Corporate Analyst Meeting TranscriptJun 25, 2020
- Q1 2020 Targovax ASA Earnings Call TranscriptMay 07, 2020kr197.61 (-7.80%)Earnings
- Q4 2019 Targovax ASA Earnings Call TranscriptMar 11, 2020kr106.56 (-10.02%)Earnings
- Targovax ASA - Pre Recorded Special Call TranscriptJan 21, 2020
- Targovax ASA - Special Call TranscriptNov 15, 2019
- Q3 2019 Targovax ASA Earnings Call TranscriptNov 07, 2019kr125.69 (+2.77%)Earnings
- Q2 2019 Targovax ASA Earnings Call TranscriptAug 22, 2019kr134.89 (-4.30%)Earnings
- Q1 2019 Targovax ASA Earnings Call TranscriptMay 09, 2019kr153.78 (-3.79%)Earnings
Targovax ASA - Special Call Transcript
Just wanted to introduce Torbjørn Furuseth, the CFO of Targovax.
¸ -
Thank you, and good afternoon, everyone. And thank you for staying through the day on a Friday afternoon. I am to represent, as [Jan] said, from Targovax. And today -- with me today also, we have Dr. Alexander Shoushtari from Memorial Sloan Kettering. Dr. Shoushtari is a melanoma expert and the principal investigator of one of our trials. So Alexander will do most of the talking today. But I just wanted to give a short introduction of Targovax first.
We are listed at the Oslo Stock Exchange in Norway, and there will be forward-looking statements. And Targovax is developing oncolytic viruses to activate the patient's immune system. And as you all know, there has been a paradigm shift in cancer therapy with the breakthrough of immunotherapy. And this shift has been led by the checkpoint inhibitors, treating and curing thousands of patients, and it's now a $20 billion market. But despite this success, only 10% to 40% of patients respond to a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
